adderall manufacturer website | 7 Risky Drugs Appears Danger Only After Great Pharmacy Make Money

7 Risky Drugs Appears Danger Only After Great Pharmacy Make Money




Have you ever noticed how warnings about dangerous prescription drugs always seem to surface after the drugs are no longer marketed and patents that have run out? Whether the FDA advises or solicits a lawyer about the harm that may have been committed to you, the warning is always too late and in vain. If the drug you took four years ago may have inflicted liver damage, Why does the FDA not tell you then? Why does the FDA not attract drugs or better? But do not approve it for the first time?

The official answer from the FDA and the Great Pharmacy is that the problem with drugs is only seen after millions start using it, which is why post marketing supervision is done. In other words-who knows? But surprisingly the number of cases revealed in the Pharmaceutical court documents "know" and clearly misleading the medical journals, FDA, doctors and patients, hopes to get a valuable patent before the true risks of the drug appear. In other cases, pharmaceuticals and the FDA should know before rushing dangerous drugs into the market and making money at the expense of patients.

This is a business model for a new drug that provokes Great Pharmacy to bury the risks and exaggerate the benefits. New drugs under the patent have a high price and no competition, and will make millions or even billions each year under the patent. The completion of death or injury on the road is a nuisance and is just a cost of doing business. Needless to say, the business plan of "forgiveness is cheaper than permission" gave birth to shameless relapse Since the company made money and the officers went to jail.

Hidden and unexpected risks in new drugs are a danger that some medical professionals advise patients to wait up to seven years before trying new drugs. Of course, this drug is no less risky when made by generic drug makers except that it has long been used and is not accompanied by slick advertisements to encourage demand and even "sell" treating conditions. But generics have their weakness, too. Unlike branded company drugs, in 2013 the Supreme Court said generic drug makers could not be prosecuted.

Here are some drugs that risk not guarding it from getting it "worthy of a patent."

1. Vioxx: remember "super aspirin" Vioxx, it's heavily marketed by Merck and athletes Dorothy Hamill and Bruce Jenner 15 years ago? Vioxx is a miracle cure that treated everything from diseased arthritis to menstrual cramps, claimed its ads, Save users of digestive problems caused by older drugs like aspirin. It turns out that Vioxx on super something else, too: it's double the risk of heart events, causing 27,785 heart attacks and sudden cardiac deaths according to news sources.

While Merck pleaded ignorance, the New England Journal of Medicine in 2006 accused Merck of hiding "important data on various adverse cardiovascular events" caused by Vioxx. It was withdrawn in 2004. In 2007, Merck agreed to pay $ 4.85 billion to patients or victims' families representing less than a year of Merck's profit, calculated in the New York Times. Vioxx made Merck estimated at $ 2.5 billion per year from the 1999 launch for withdrawal in 2004. Who says crime does not pay?

2. Fosamax: Vioxx is not just a drug Merck suggests that forgiveness is easier and cheaper when it comes to marketing new drugs. Merck Fosamax, the first of a class of anti-osteoporosis drugs called biphosphonates including Boniva and Actonel, is associated with heart problems, non-healing pain, jaw bone death, fractures and esophageal cancer only after its patent out in 2008. The issued court revealed that Merck scientists knew about Fosamax 'associated with jaw bone death as early as the 1970s in animal studies.

There's even a subplot for Merck's lies. "Companies are installing bone density scanners in medical offices across the US to frighten women to take Fosamax if their scans reveal bone thinning, reported National Public Radio. The trickery of "selling" bone thinning disease to sell Fosamax does not make a big dent in sales when it comes to light: Fosamax's already gone patent.
3. Lipitor: Which drugs are the bestsellers in the history of drugs? What makes $ 125 billion in 14 and half years and as much as $ 11 billion in one year? Lipitor, the blockbuster statin drug Pfizer, owes its success to two factors. It was launched in 1997 when drug advertising directly to consumers has just started and it's harnessing growing national fear of cholesterol-related heart attacks. Thanks to "Know Your Numbers" Lipitor TV ads and Pfizer representatives who saturate medical offices with free samples of white pills and sometimes lunches, more than 29 million people are prescribed Lipitor.

But in 2012-the same year Lipitor's patent has ended-29 million people (and millions taking other statins) got a shock from the FDA. The agency made warning label changes that Lipitor and other statins can cause diabetes, liver injury, muscle damage and memory impairment. Who knows ? The quartet of concern "should not scare people off statins," said Amy G. Egan, deputy director for safety in the FDA's Division of Metabolism and Endocrinology Products. Correct.

4. Nexium: What is the second best-selling drug, after Lipitor? Purple Pills Like statins, Nexium and other Proton-Pump Inhibitors (PPIs) to treat gastroesophageal reflux (GERD) diseases, become household remedies thanks to direct advertising to consumers. Prior to Proton-Pump Inhibitors, people take treatments such as Tums or Tagamet when they are heartburn or indigestion. As the suffering increased to the "illness" of GERD, Nexium made nearly $ 5 billion in the US within a year and the PPI class made $ 13.6 billion in one year, translating into 119 million recipes.

In 2012, the same year the FDA warned about statins, the FDA warned the public that Nexium and all of the PPI classes are linked to Clostridium difficile, intestinal and sometimes lethal infections that are increasingly drug resistant and difficult to treat. In 2013, medical literature connects PPIs with fractures, calcium and magnesium deficiency, community-acquired pneumonia and vitamin B-12 deficiency. Research by John P. Cooke, a clinical professor at Methodist Hospital in Houston, discovered in 2013 that PPIs can cause blood vessels to constrict and cardiovascular risk. Not a great end to the Nexium blockbuster, whose patent runs out in 2014.

5. Adderall: It is no secret that doctors, parents and teachers are contacted by millions of ADHD children. Thanks to marketing Pharma, ADHD is now the second most common long-term diagnosis in children after asthma, the New York Times says, is often given for "children's forgetting and poor grades." While some critics of large doses say children are being punished for being children and that "treatment" is used to be a recess, the Great Pharmaceutical Rotating Camp maintains that everyday stimulants do not hurt children.

However in 2009, the same year Adderall XR out patent (Dan two years Before the Concert, a time-release version of Ritalin out patent) Study in the American Journal of Psychiatry found a drug that actually Kills the Child. There was "A significant relationship of use of stimulants with sudden unexplained deaths arising from primary analysis," wrote the authors who looked at 564 sudden death cases in children 7-19. Pharmaceutical Pro-stimulant Doctors denied the study, saying the drug might delay the death of the user by improving their driving skills. Why does not anyone test that?

6. Paxil: some SSRI antidepressants have a safety profile of the Paxil GlaxoSmithKline (GSK) checkbox. In 2007 the BBC revealed that the Paxil 329 Study showed teens were six times more likely to be suicidal on drugs but the results were buried. (GSK stipulates a 2012 related cost of $ 3 billion.) Rumors have been circulating for years about suicide and toxic withdrawal symptoms with Paxil and they are clearly true in some cases.
In 2005, the FDA revealed birth defects associated with Paxil including heart malformations. (Babies may also have "seizures, changing body temperature, breastfeeding problems, vomiting, low blood sugar, lethargy, stiffness, vibration, shakiness, irritability or constant crying," warns Paxil website.) Nerves with business models "more forgiveness cheaper than permission ", when Paxil risks appearing, GSK has taken the money and left. In fact, Paxil made 2.12 billion for GSK in 2002, last year under a patent, and a method of rehashing the veteran Iraq war of PTSD.

7. Ambien: One of the Big Pharmaceutical dairy cows is an insomnia pill, because everyone watches TV when they can not sleep and they see a pill ad. Leading the sleeping pills category is Sanofi-Aventis' Ambien, which netted $ 2 billion a year before dismissing the patent in 2006. But even as the patent ends, the story begins to circulate about the crazy behavior committed in the Ambien blackout. The man drove and made a phone call on the medicine without remembering the dieter waking up amid the pizza mountains and the Haagen-Dazs carton, and a woman drinking a bottle of black shoe polish in the Ambien blackout. (Sanofi-Aventis was forced to publish advertisements telling people if they would take Ambien, to get in bed and stay there.)

In 2012, Mayo clinics in Rochester announced no longer prescribing Ambien for inpatients because of its falling rate - quadruple of patients who were not Ambien and greater than fall caused by age, mental disorders or delirium. In 2013, the FDA warns about Ambien drunkenness, where the drug does not leave the body, and is recommended a lower dose, especially for women. The warning came too late for Kerry Kennedy, the daughter of Robert F. Kennedy and former wife of New York Governor Andrew Cuomo. Witnesses said he had weaved for miles when he swerved into the tractor-trailer and kept driving, during the summer of 2012. Kennedy told police he might have taken Ambien into thinking it was a daily thyroid remedy.

For a weekly news gathering and developments in the drug Reform movement and injustice stemming from a ban, register to receive AlterNet's Drugs newspaper here. Be sure to scroll down to "Drug" and subscribe!

Martha Rosenberg is a health investigative reporter and author of Born With a Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (book Prometheus).